Viral vectors as vaccine platforms: from immunogenicity to impact. (2016)
Attributed to:
A novel vaccine for broad protection against meningococcal disease: progression to phase I clinical trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.coi.2016.05.014
PubMed Identifier: 27286566
Publication URI: http://europepmc.org/abstract/MED/27286566
Type: Journal Article/Review
Volume: 41
Parent Publication: Current opinion in immunology
ISSN: 0952-7915